Tertiary lymphoid structures marker CXCL13 is associated with better survival for patients with advanced-stage bladder cancer treated with immunotherapy

著者: Clarice S. Groeneveld, Jacqueline Fontugne, Luc Cabel, Isabelle Bernard‐Pierrot, François Radvanyi, Yves Allory, Aurélien de Reyniès - European Journal of Cancer 2021 被引用: 153